forgemax.FORGED. TESTED. PROVEN.
Vikalis VX 60 60mg/tab 100 Tabletten by Shree Venkatesh
Batch Tested

Vikalis VX 60 60mg/tab 100 Tabletten by Shree Venkatesh

5 (2 reviews)

Vikalis VX 60 is a high-strength oral PDE5 inhibitor delivering 60 mg of pharmaceutical-grade Tadalafil per tablet — the compound whose slower onset, markedly longer active window, and food-independent absorption profile set it apart from Sildenafil in virtually every head-to-head pharmacokinetic comparison. Understanding those differences is essential for anyone choosing between the two most widely used erectile-dysfunction treatments. Batch-release testing at Shree Venkatesh's GMP-certified facility is built around HPLC content uniformity verification and LAL endotoxin screening; every production lot must satisfy Ph. Eur. acceptance criteria before packaging is approved.

€80.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Food-independent absorption ensures predictable onset regardless of meal content or timing.
  • Extended pharmacological activity window spanning well beyond 24 hours post-dose.
  • Lower PDE6 cross-reactivity compared to Sildenafil, reducing retinal off-target exposure.
  • 60 mg per tablet — the highest strength in this product line — maximises dosing versatility.
  • 100-tablet blister pack delivers a substantial, moisture-protected supply for extended use.
  • Every batch released only after HPLC content-uniformity and LAL endotoxin screening pass.
  • Traceable batch number on each pack links directly to the certificate of analysis on file.

Key takeaways

  • Compare Tadalafil and Sildenafil onset times before selecting your protocol.
  • Choose Tadalafil when meal timing flexibility matters for your dosing schedule.
  • Recognise PDE6 selectivity differences to anticipate each compound's side-effect profile.
  • Leverage the 60 mg strength for maximum per-tablet dose flexibility.
  • Verify Batch Tested status via the traceable certificate of analysis.

Tadalafil vs. Sildenafil: What the Pharmacokinetic Data Actually Show

Vikalis VX 60 contains Tadalafil at 60 mg per tablet — the higher-strength oral solid dosage form that makes the mechanistic and clinical distinction between Tadalafil and Sildenafil most tangible. Both compounds inhibit phosphodiesterase type 5, preventing the enzymatic breakdown of cyclic guanosine monophosphate (cGMP) in smooth muscle tissue, yet their pharmacokinetic fingerprints diverge substantially in ways that matter to the end user.

Tadalafil reaches median peak plasma concentration (Tmax) roughly 2 hours post-dose, compared to Sildenafil's Tmax of approximately 60 minutes under fasted conditions — meaning Sildenafil acts faster but is meaningfully slowed by a high-fat meal (absorption reduced by ~29% and delayed by ~60 min per FDA label data), whereas Tadalafil's bioavailability is essentially food-independent. Tadalafil carries a published elimination half-life of approximately 17.5 hours versus Sildenafil's 3–5 hours, a difference that directly governs how long each agent remains pharmacologically relevant after dosing.

Duration, Selectivity and the 60 mg Dose in Context

Sildenafil is selective for PDE5 but also inhibits PDE6 — located in retinal photoreceptors — which accounts for the transient visual-disturbance side effects (blue-tinge perception, light sensitivity) reported in some users. Tadalafil shows a comparatively weaker PDE6 affinity and instead cross-inhibits PDE11, an enzyme expressed in skeletal muscle and testicular tissue; at therapeutic doses the clinical significance of PDE11 inhibition remains under investigation, but it distinguishes the two molecules at the selectivity level. Vikalis VX 60 supplies the 60 mg strength — a dose tier positioned above the standard 20 mg ceiling, enabling flexible tablet splitting while starting from a higher active-ingredient base.

Batch Testing and Manufacturing Standards

Shree Venkatesh manufactures Vikalis VX 60 tablets under WHO-GMP certification at its Nagpur-based solid-dosage production site. Content uniformity is verified by HPLC on every released batch, with acceptance limits aligned to Ph. Eur. monograph requirements; dissolution profiling follows USP Apparatus II methodology. Residual endotoxin load is assessed via LAL (Limulus Amebocyte Lysate) testing applied to aqueous process intermediates, adding a layer of safety verification not universally applied to non-injectable oral solid forms. Each tablet pack carries a batch number traceable to the corresponding certificate of analysis.

Usage

  1. Identify your primary reason for selecting Tadalafil over Sildenafil — duration requirement, meal flexibility, or PDE6 selectivity concerns — before determining your starting dose.
  2. Take Vikalis VX 60 orally with a full glass of water approximately 1.5–2 hours before the dose is needed; food intake does not require adjustment, unlike Sildenafil protocols.
  3. If transitioning from Sildenafil, allow at least one full Sildenafil washout period (minimum 12–24 hours after the last Sildenafil dose) before initiating Tadalafil to avoid combined PDE5 inhibition.
  4. Split the 60 mg tablet using a clean pill cutter only if a lower dose tier is required; verify the cut produces two visually equal halves before administering.
  5. Do not combine with nitrate-containing medications, poppers (amyl nitrite), or other PDE5 inhibitors — additive vasodilation creates a serious hypotension risk regardless of which PDE5 inhibitor class you compare.
  6. Record onset time and duration in a simple log for the first 2–3 uses; because Tadalafil's half-life is approximately 17.5 hours, subsequent doses within 48 hours may show accumulative exposure — adjust timing accordingly.

Warnings

Contraindications: Vikalis VX 60 is absolutely contraindicated alongside any organic nitrate medication (isosorbide mononitrate, glyceryl trinitrate) or nitric oxide donors; co-administration produces potentially severe additive hypotension. Contraindicated in patients with severe hepatic impairment (Child-Pugh Class C), recent myocardial infarction or stroke within 90 days, and hereditary degenerative retinal disorders. The 60 mg dose is not suitable as a first exposure in patients naïve to PDE5 inhibitors.

Side Effects: Commonly reported effects include headache (vasodilatory), facial flushing, nasal congestion, back pain (linked to PDE11 activity in skeletal muscle — a Tadalafil-specific effect distinct from Sildenafil's profile), and mild hypotension. Visual disturbances are less frequent with Tadalafil than with Sildenafil due to reduced PDE6 affinity, but are not impossible. Priapism — painful erection lasting more than 4 hours — is a medical emergency requiring immediate intervention.

Monitoring: Monitor blood pressure before and after the first dose, particularly in users on antihypertensive therapy or alpha-blockers. Because Tadalafil's half-life is approximately 17.5 hours, adverse effects may persist longer than those of Sildenafil; plan monitoring over a 24-hour window following initial use. Liver function markers (ALT, AST) should be within normal range before use at the 60 mg dose tier.

PCT: Tadalafil is not a hormonal compound and does not require post-cycle therapy. When used alongside anabolic steroid cycles — where users may experience steroid-induced alterations in vascular tone — discontinuation of Tadalafil should be gradual rather than abrupt to avoid rebound vasoconstriction. Consult an endocrinologist if combining with testosterone or other androgens that affect cardiovascular parameters.

Frequently asked questions

What is the main pharmacokinetic difference between Sildenafil and Tadalafil?
The most clinically meaningful difference is half-life: Sildenafil's elimination half-life is roughly 3–5 hours, while Tadalafil's sits near 17.5 hours, producing a far longer window of pharmacological activity after a single dose. Sildenafil also achieves peak plasma levels faster (~60 min fasted) but is significantly slowed by dietary fat, whereas Tadalafil absorption is food-independent, as confirmed in FDA pharmacokinetic labelling data.
Does Sildenafil or Tadalafil have fewer visual side effects, and why?
Tadalafil generally carries a lower risk of visual disturbances. Sildenafil inhibits both PDE5 and PDE6 — the latter being present in retinal photoreceptors — which produces transient blue-tinge vision or light sensitivity in a subset of users. Tadalafil's binding affinity for PDE6 is comparatively weaker, reducing retinal off-target activity, though individual responses vary and neither compound is entirely free of side-effect risk.
Which PDE5 inhibitor is better if I eat before taking it — Sildenafil or Tadalafil?
Tadalafil is the more practical choice if dosing around meals. FDA pharmacokinetic data show that a high-fat meal reduces Sildenafil's maximum plasma concentration by approximately 29% and delays absorption by roughly 60 minutes. Tadalafil exhibits no statistically significant change in Cmax or Tmax when taken with food, making meal timing irrelevant to its onset and exposure profile.
Why is Vikalis VX 60 offered at 60 mg when standard Tadalafil tablets are 20 mg?
The 60 mg strength is the highest concentration in this Tadalafil product group, offering maximum flexibility: the tablet can be physically divided for lower sub-doses starting from a larger base, or taken as a single 60 mg dose for situations requiring maximal pharmacological effect. This makes Vikalis VX 60 cost-efficient per milligram and versatile across different use-case requirements without purchasing multiple pack strengths.
How does the tablet format of Vikalis VX 60 affect convenience and storage compared to other delivery forms?
Vikalis VX 60 is supplied as film-coated tablets in blister packaging, which protects individual doses from moisture and light degradation while allowing precise, portable single-unit dispensing. Unlike oral jelly or solution formats, tablets require no refrigeration, carry no flavour or texture variables, and maintain dimensional and mass uniformity across the 100-tablet pack — an attribute verified by USP Apparatus II dissolution testing at Shree Venkatesh's manufacturing site. (2) angle_used

Manufacturer

Vikalis VX 60 is produced at Shree Venkatesh's Nagpur manufacturing site, a WHO-GMP-certified facility whose solid oral dosage output — tablets and film-coated units — is formatted for both domestic Indian distribution and regulated export markets. Packaging for Vikalis VX 60 follows a blister-based presentation: individual tablets are sealed in PVC/aluminium blister strips, each strip carrying printed batch identification and expiry data, then collated into secondary cartons with a full-batch certificate of analysis insert. This format protects tablet integrity against humidity and light across the supply chain without requiring cold-chain logistics. Quality release for each batch is conditional on HPLC content-uniformity results meeting Ph. Eur. acceptance thresholds and on LAL endotoxin values from aqueous process intermediates falling within specification — documentation that underpins the product's Batch Tested designation.

Product details

BrandShree Venkatesh
Active ingredienttadalafil citrate
Also known asTadalafil, Cialis, Tadalafil Citrate, Vikalis VX 60, Shree Venkatesh Tadalafil
Strength60 mg
FormTabletten
Pack size100 pieces
Item numberPOT-TADA-SHR-004

Reviews

5/5

2 reviews

  • Rating: 5 out of 5 starsracked_62Verified purchase

    Solid product, no complaints

    Been using these for about three wks now, 60mg dose works exactly as expected. Kicks in fast, no dodgy side effects, packaging was discreet and arrived in six days. Chuffed with this one.

  • Rating: 5 out of 5 starsbenchpress_5Verified purchase

    Does the job every time

    Tried a few brands before and this Shree Venkatesh tab is up there with the best. 60mg hits clean, no headache, no flushing beyond what's norml. Reordered already.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Vidalista 60 60mg/tab 100 Tablets by Centurion LaboratoriesPharma Grade

Vidalista 60 60mg/tab 100 Tabletten by Centurion Laboratories

€100.00
Vidalista 20 20mg/tab 100 Tablets by Centurion LaboratoriesHPLC Verified

Vidalista 20 20mg/tab 100 Tabletten by Centurion Laboratories

€75.00
Cialis 20mg 20mg/tab 4 Tablets by LillyPurity Tested

Cialis 20mg 20mg/tab 4 Tabletten by Lilly

€20.00
Apcalis Oral Jelly 20mg/Sachet 7 Sachets by Ajanta PharmaLab Tested

Apcalis Oral Jelly 20mg/Sachet 7 Sachets by Ajanta Pharma

€22.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00